Skip to main content
. 2014 Sep 19;9(9):e108270. doi: 10.1371/journal.pone.0108270

Figure 2. INT-767 reduces high fat-induced adiposity and hyperlipidemia in LDLR−/− mice.

Figure 2

Mice were treated with INT-767 as indicated in the Methods section. A) Body weight of LDLR−/− mice treated with INT-767. B) White fat weight of ApoE−/− mice. C) Cholesterol distribution in the lipoproteins of LDLR−/− mice treated with INT-767. D) Triglyceride distribution in the lipoproteins of mice treated with INT-767. **P<0.001 and ***P<0.001.